Studies

CAVA study – COVID-19 Capillary And Venous blood Antibody testing study

Speciality area
Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Professor Nick Wareham

Developing array typing of blood cell antigens for clinical care

Speciality area
Haematology

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Professor Emanuele Di Angelantonio

How does the severe critical illness driven by COVID19 encode its long-term effects?

Speciality area
Infection

Study type
Samples and data

Researcher type
Unassigned

Research lead
Dr Alasdair Jubb

Determining risk for extravascular haemolysis in paroxysmal nocturnal haemoglobinuria patients treated with eculizumab

Speciality area
Haematology, Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Professor Claire Harris

Developing Protocols for Modelling of Genetic Diseases using induced Pluripotent Stem Cells

Speciality area
Ageing, Ophthalmology

Study type
Participant re-contact

Researcher type
Commerical

Research lead
Dr Alex Armesilla (Dr Alejandro Armesilla-Diaz)

Complement activation to predict Sars-CoV-2 outcome

Speciality area
Infection

Study type
Samples and data

Researcher type
Non-commercial

Research lead
Dr Richard Unwin

Healthcare Worker Case Control COVID-19 Questionnaire

Speciality area
Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Dan Cooper

Healthcare Worker COVID follow up

Speciality area
Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Dan Cooper

Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patients

Speciality area
Gastroenterology

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Professor Graham Lord